SEI Investments’s LB Pharmaceuticals LBRX Stock Holding History

SEI Investments’s Portfolio LBRX Stock Details LBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$409K	Buy	+12,611	New	+$370K	﹤0.01%	2723

Other funds holding LBRX

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SEI Investments's LBRX Position: Q2 2026 in Review

SEI Investments opened a new position in LB Pharmaceuticals (LBRX) in Q2 2026: 12,611 shares worth $409K. The stake represents ﹤0.01% of the portfolio and ranks #2723 among its holdings.

115 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

SEI Investments held 12,611 shares of LB Pharmaceuticals worth $409K as of Q2 2026.
LB Pharmaceuticals was a new SEI Investments position in Q2 2026.
LB Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2723 holding.
115 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.